{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:59:52Z","timestamp":1790085592538,"version":"4.0.1"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018628","name":"Scientific Research Foundation of Education Department of Anhui Province of China","doi-asserted-by":"publisher","award":["2022AH050718"],"award-info":[{"award-number":["2022AH050718"]}],"id":[{"id":"10.13039\/501100018628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2023xkjT012"],"award-info":[{"award-number":["2023xkjT012"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopha.2026.119915","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:53:27Z","timestamp":1789077207000},"page":"119915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Context-dependent roles of cGAS\u2013STING signaling in glioblastoma: Therapeutic resistance, drug delivery, and heterogeneity-informed translation"],"prefix":"10.1016","volume":"203","author":[{"given":"Yuzhu","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongcui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuru","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewenjing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3740-8109","authenticated-orcid":false,"given":"Tongchao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119915_bib1","first-page":"360","article-title":"Glioblastoma microenvironment\u2014from biology to therapy","author":"Read","year":"2024","journal-title":"Genes. Dev. 38"},{"key":"10.1016\/j.biopha.2026.119915_bib2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/OP.22.00476","article-title":"Key Clinical Principles in the Management of Glioblastoma","volume":"19","author":"Kotecha","year":"2023","journal-title":"JCO Oncol. Pract."},{"key":"10.1016\/j.biopha.2026.119915_bib3","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2026.119915_bib4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.biopha.2026.119915_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cytogfr.2025.06.002","article-title":"Metabolic Regulation of cGAS-STING Signaling in the Tumor Microenvironment: Dual Immune Roles and Therapeutic Implications","volume":"85","author":"Wu","year":"2025","journal-title":"Cytokine Growth Factor. Rev."},{"key":"10.1016\/j.biopha.2026.119915_bib6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ccell.2022.04.009","article-title":"Epigenetic STING silencing is developmentally conserved in gliomas and can be rescued by methyltransferase inhibition","volume":"40","author":"Low","year":"2022","journal-title":"Cancer Cell."},{"key":"10.1016\/j.biopha.2026.119915_bib7","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2100225118","article-title":"TBK1 recruitment to STING activates both IRF3 and NF-\u03baB that mediate immune defense against tumors and viral infections","volume":"118","author":"Yum","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119915_bib8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/2159-8290.CD-23-0700","article-title":"TREX1 Inactivation Unleashes Cancer Cell STING-Interferon Signaling and Promotes Antitumor Immunity","volume":"14","author":"Tani","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2026.119915_bib9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41467-023-36132-9","article-title":"ESCRT-dependent STING degradation inhibits steady-state and cGAMP-induced signalling","volume":"14","author":"Gentili","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119915_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163452","article-title":"Understanding and therapeutically exploiting cGAS\/STING signaling in glioblastoma","volume":"134","author":"Low","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2026.119915_bib11","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111003119","article-title":"STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models","volume":"119","author":"Berger","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119915_bib12","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1158\/0008-5472.CAN-23-0046","article-title":"Galectin-1 Mediates Chronic STING Activation in Tumors to Promote Metastasis through MDSC Recruitment","volume":"83","author":"Nambiar","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2026.119915_bib13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-022-04847-2","article-title":"cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers","volume":"607","author":"Hong","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119915_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-023-02676-9","article-title":"The niche matters: origin, function and fate of CNS-associated macrophages during health and disease","volume":"147","author":"Dalmau Gasull","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2026.119915_bib15","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1158\/1078-0432.CCR-23-0118","article-title":"Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies","volume":"29","author":"Luke","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119915_bib16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1146\/annurev-immunol-101721-032910","article-title":"Regulation of the cGAS-STING Pathway","volume":"43","author":"Zhang","year":"2025","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2026.119915_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.neuron.2023.10.014","article-title":"STING signaling in the brain: Molecular threats, signaling activities, and therapeutic challenges","volume":"112","author":"Yang","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2026.119915_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41392-022-01093-w","article-title":"STING cg16983159 methylation: a key factor for glioblastoma immunosuppression","volume":"7","author":"Qiu","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2026.119915_bib19","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/s41388-025-03454-5","article-title":"Post-translational modifications in DNA damage repair: mechanisms underlying temozolomide resistance in glioblastoma","volume":"44","author":"Chen","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119915_bib20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1158\/2326-6066.CIR-14-0099","article-title":"STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment","volume":"2","author":"Ohkuri","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.biopha.2026.119915_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119915_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119915_bib23","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.molcel.2024.04.017","article-title":"Micronuclei induced by radiation, replication stress, or chromosome segregation errors do not activate cGAS-STING","volume":"84","author":"Takaki","year":"2024","journal-title":"Mol. Cell."},{"key":"10.1016\/j.biopha.2026.119915_bib24","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41586-023-06464-z","article-title":"Non-cell-autonomous cancer progression from chromosomal instability","volume":"620","author":"Li","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119915_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1236824","article-title":"The immune cell landscape of glioblastoma patients highlights a myeloid-enriched and immune suppressed microenvironment compared to metastatic brain tumors","volume":"14","author":"Musca","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2026.119915_bib26","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/s41586-025-08633-8","article-title":"Programs, origins and immunomodulatory functions of myeloid cells in glioma","volume":"640","author":"Miller","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119915_bib27","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41467-022-28523-1","article-title":"T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10","volume":"13","author":"Ravi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119915_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175033","article-title":"STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma","volume":"134","author":"Najem","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2026.119915_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12964-024-01523-y","article-title":"Hypoxic glioblastoma-cell-derived extracellular vesicles impair cGAS-STING activity in macrophages","volume":"22","author":"Tankov","year":"2024","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.biopha.2026.119915_bib30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41556-025-01839-y","article-title":"Inhibiting macrophage-derived lactate transport restores cGAS-STING signalling and enhances antitumour immunity in glioblastoma","volume":"28","author":"Li","year":"2026","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.biopha.2026.119915_bib31","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1158\/2767-9764.CRC-23-0189","article-title":"NLRP3 Inflammasome Activation Expands the Immunosuppressive Myeloid Stroma and Antagonizes the Therapeutic Benefit of STING Activation in Glioblastoma","volume":"5","author":"Lea","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.biopha.2026.119915_bib32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.devcel.2021.12.007","article-title":"Quiescent human glioblastoma cancer stem cells drive tumor initiation, expansion, and recurrence following chemotherapy","volume":"57","author":"Xie","year":"2022","journal-title":"Dev. Cell."},{"key":"10.1016\/j.biopha.2026.119915_bib33","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191340","article-title":"Glioma stem-like cells evade interferon suppression through MBD3\/NuRD complex-mediated STAT1 downregulation","volume":"217","author":"Zhan","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2026.119915_bib34","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41467-025-67119-3","article-title":"Targeting chaperone-mediated autophagy inhibits properties of glioblastoma stem cells and restores anti-tumor immunity","volume":"17","author":"Li","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119915_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccr.2006.11.020","article-title":"A perivascular niche for brain tumor stem cells","volume":"11","author":"Calabrese","year":"2007","journal-title":"Cancer Cell."},{"key":"10.1016\/j.biopha.2026.119915_bib36","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","article-title":"Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression","volume":"56","author":"Sattiraju","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2026.119915_bib37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41556-023-01098-9","article-title":"STING signalling is terminated through ESCRT-dependent microautophagy of vesicles originating from recycling endosomes","volume":"25","author":"Kuchitsu","year":"2023","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.biopha.2026.119915_bib38","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature07317","article-title":"STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling","volume":"455","author":"Ishikawa","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119915_bib39","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.immuni.2020.03.004","article-title":"The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling","volume":"52","author":"Mohamed","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2026.119915_bib40","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41419-024-06936-8","article-title":"Triggering of endoplasmic reticulum stress via ATF4-SPHK1 signaling promotes glioblastoma invasion and chemoresistance","volume":"15","author":"Lan","year":"2024","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.biopha.2026.119915_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14839","article-title":"The unfolded protein response machinery in glioblastoma genesis, chemoresistance and as a druggable target","volume":"30","author":"Simbilyabo","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biopha.2026.119915_bib42","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.7150\/thno.128135","article-title":"STING signaling pathway: An oasis in the glioblastoma immune desert","volume":"16","author":"Wang","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2026.119915_bib43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11060-026-05601-8","article-title":"cGAS-STING agonists in preclinical glioblastoma animal models: a systematic review of tumor microenvironment modulation and survival outcomes","volume":"177","author":"Sampath","year":"2026","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.biopha.2026.119915_bib44","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1158\/2326-6066.CIR-21-1050","article-title":"Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes","volume":"10","author":"Alanio","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.biopha.2026.119915_bib45","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nature10429","article-title":"STING is a direct innate immune sensor of cyclic di-GMP","volume":"478","author":"Burdette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119915_bib46","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.molcel.2013.05.022","article-title":"Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING","volume":"51","author":"Zhang","year":"2013","journal-title":"Mol. Cell."},{"key":"10.1016\/j.biopha.2026.119915_bib47","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jconrel.2020.11.017","article-title":"Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration","volume":"330","author":"Wehbe","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2026.119915_bib48","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nchembio.1661","article-title":"Hydrolysis of 2\u20323'-cGAMP by ENPP1 and design of nonhydrolyzable analogs","volume":"10","author":"Li","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2026.119915_bib49","first-page":"232","article-title":"Targeted delivery of a STING agonist to brain tumors using bioengineered protein nanoparticles for enhanced immunotherapy","volume":"16","author":"Wang","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.biopha.2026.119915_bib50","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","article-title":"Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced\/Metastatic Solid Tumors or Lymphomas","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119915_bib51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41582-022-00621-0","article-title":"Advances in local therapy for glioblastoma\u2014taking the fight to the tumour","volume":"18","author":"van Solinge","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2026.119915_bib52","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.1158\/1078-0432.CCR-21-1914","article-title":"Intratumoral Delivery of STING Agonist Results in Clinical Responses in Canine Glioblastoma","volume":"27","author":"Boudreau","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119915_bib53","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.4049\/jimmunol.1300097","article-title":"Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid","volume":"190","author":"Conlon","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2026.119915_bib54","article-title":"situ administration of STING-activating hyaluronic acid conjugate primes anti-glioblastoma immune response","volume":"26","author":"Chellen","year":"2024","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biopha.2026.119915_bib55","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41467-023-37328-9","article-title":"STING agonist-loaded, CD47\/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119915_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202512104","article-title":"A Sono-Responsive Nanoplatform Integrating STING Activation and CXCR4 Blockade for Synergistic Immunotherapy of Glioblastoma","volume":"38","author":"Kang","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biopha.2026.119915_bib57","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1039\/D0NH00446D","article-title":"Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors","volume":"6","author":"Bielecki","year":"2021","journal-title":"Nanoscale Horiz."},{"key":"10.1016\/j.biopha.2026.119915_bib58","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12951-026-04055-4","article-title":"RAP-peptide functionalized biomimetic nanoformulation with pathological ROS\/pH-responsive drug release for target immunotherapy in glioma","volume":"24","author":"Li","year":"2026","journal-title":"J. Nanobiotechnol"},{"key":"10.1016\/j.biopha.2026.119915_bib59","article-title":"A Manganese-Based Nanodriver Coordinates Tumor Prevention and Suppression through STING Activation in Glioblastoma","volume":"13","author":"Zhang","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2026.119915_bib60","article-title":"Smart organic-inorganic copolymer nanoparticles distinguish between microglia and cancer cells for synergistic immunotherapy in glioma","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.biopha.2026.119915_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adx9671","article-title":"STING stimulation via supramolecular prodrug hydrogel boosts innate-adaptive immune cross-talk to prevent glioblastoma recurrence","volume":"12","author":"Shang","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2026.119915_bib62","article-title":"Sequential Release HydroLipo System for STING Gene Epigenetic Reprogramming and Immune Activation in Glioblastoma","volume":"12","author":"Yu","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.biopha.2026.119915_bib63","doi-asserted-by":"crossref","first-page":"13266","DOI":"10.1021\/acsnano.4c02425","article-title":"Situ Sprayed Exosome-Cross-Linked Gel as Artificial Lymph Nodes for Postoperative Glioblastoma Immunotherapy","volume":"18","author":"Bao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2026.119915_bib64","article-title":"Chimeric Exosomes Functionalized with STING Activation for Personalized Glioblastoma Immunotherapy","volume":"11","author":"Bao","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.biopha.2026.119915_bib65","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12951-025-03301-5","article-title":"Radiotherapy-derived engineered stem cell exosomes improve anti-glioma immunotherapy by promoting the formation of tertiary lymphoid structure and improve the release of type I interferon","volume":"23","author":"Li","year":"2025","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.biopha.2026.119915_bib66","article-title":"Comparison of nose-to-brain and systemic delivery of STING agonist-loaded liposomes for glioblastoma treatment","volume":"109","author":"Kotmakci","year":"2025","journal-title":"J. Drug. Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2026.119915_bib67","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409557122","article-title":"cGAS-agonistic spherical nucleic acids reprogram the glioblastoma immune microenvironment and promote antitumor immunity","volume":"122","author":"Mahajan","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119915_bib68","doi-asserted-by":"crossref","DOI":"10.1172\/JCI198843","article-title":"STING-induced blood-brain barrier opening combined with radiotherapy potentiates antitumor response in a high-grade glioma model","volume":"136","author":"Tripathi","year":"2026","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2026.119915_bib69","doi-asserted-by":"crossref","first-page":"607","DOI":"10.55730\/1300-0144.5828","article-title":"STING activation increases the efficiency of temozolomide in PTEN harbouring glioblastoma cells","volume":"54","author":"Yildirim","year":"2024","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.biopha.2026.119915_bib70","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1038\/s41388-022-02397-5","article-title":"GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair","volume":"41","author":"Xu","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2026.119915_bib71","doi-asserted-by":"crossref","first-page":"483","DOI":"10.18632\/oncotarget.28370","article-title":"GBP3-STING interaction in glioblastoma coordinates autophagy, anti-oxidative, and DNA repair programs in response to temozolomide","volume":"14","author":"Ma","year":"2023","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2026.119915_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119915_bib73","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adj3945","article-title":"STING licensing of type I dendritic cells potentiates antitumor immunity","volume":"9","author":"Wang","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biopha.2026.119915_bib74","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1038\/s41467-026-70221-9","article-title":"Dual phagocytosis-checkpoint blockade revitalizes immune surveillance in mouse models of glioblastoma","volume":"17","author":"Ha","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119915_bib75","doi-asserted-by":"crossref","DOI":"10.1172\/JCI149258","article-title":"Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma","volume":"132","author":"Chen","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2026.119915_bib76","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1158\/1078-0432.CCR-22-2235","article-title":"Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced\/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study","volume":"29","author":"Meric-Bernstam","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2026.119915_bib77","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00401-024-02831-w","article-title":"Functional profiling of murine glioma models highlights targetable immune evasion phenotypes","volume":"148","author":"Mikolajewicz","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biopha.2026.119915_bib78","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1501137","article-title":"Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models","volume":"7","author":"Genoud","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biopha.2026.119915_bib79","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ijrobp.2026.04.013","article-title":"Mechanisms, Microenvironments, and Models: Understanding Therapeutic Resistance in Glioblastoma","volume":"125","author":"Wisdom","year":"2026","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.biopha.2026.119915_bib80","first-page":"5443","article-title":"ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors","author":"B\u00e4hr","year":"2017","journal-title":"Oncol. Lett. 14"},{"key":"10.1016\/j.biopha.2026.119915_bib81","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154229","article-title":"H3.3-G34 mutations impair DNA repair and promote cGAS\/STING-mediated immune responses in pediatric high-grade glioma models","volume":"132","author":"Haase","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2026.119915_bib82","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2119189119","article-title":"ENPP1\u2019s regulation of extracellular cGAMP is a ubiquitous mechanism of attenuating STING signaling","volume":"119","author":"Carozza","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119915_bib83","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1038\/s41467-023-40579-1","article-title":"Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment","volume":"14","author":"Cai","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119915_bib84","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12974-025-03451-1","article-title":"Diffuse traumatic brain injury induced stimulator of interferons (STING) signaling in microglia drives cortical neuroinflammation, neuronal dysfunction, and impaired cognition","volume":"22","author":"Packer","year":"2025","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2026.119915_bib85","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1038\/s41467-022-29912-2","article-title":"Cell-lineage controlled epigenetic regulation in glioblastoma stem cells determines functionally distinct subgroups and predicts patient survival","volume":"13","author":"Lu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119915_bib86","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64090","article-title":"Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival","volume":"10","author":"Guilhamon","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2026.119915_bib87","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/s41591-018-0156-x","article-title":"The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space","volume":"24","author":"Klughammer","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2026.119915_bib88","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40478-024-01769-0","article-title":"Spatial transcriptomics reveals segregation of tumor cell states in glioblastoma and marked immunosuppression within the perinecrotic niche","volume":"12","author":"Liu","year":"2024","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.biopha.2026.119915_bib89","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13073-023-01207-1","article-title":"Spatially resolved transcriptomic profiles reveal unique defining molecular features of infiltrative 5ALA-metabolizing cells associated with glioblastoma recurrence","volume":"15","author":"Andrieux","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.biopha.2026.119915_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216480","article-title":"STING activation counters glioblastoma by vascular alteration and immune surveillance","volume":"579","author":"Joseph","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119915_bib91","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","article-title":"Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma","volume":"25","author":"Cloughesy","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2026.119915_bib92","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1038\/s41467-021-24293-4","article-title":"Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1","volume":"12","author":"Lu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2026.119915_bib93","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00262-025-04193-y","article-title":"Intratumoral B cell and interferon signatures in newly diagnosed glioblastoma are associated with longer survival in patients treated with SurVaxM","volume":"74","author":"Withers","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.biopha.2026.119915_bib94","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1038\/s41418-019-0302-0","article-title":"STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell. Death Differ."},{"key":"10.1016\/j.biopha.2026.119915_bib95","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178628","article-title":"Dual targeting macrophages and microglia is a therapeutic vulnerability in models of PTEN-deficient glioblastoma","volume":"134","author":"Liu","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2026.119915_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217856","article-title":"Dual blockade of PD-1 and CTLA-4 generates long-lasting immunity against irradiated glioblastoma","volume":"628","author":"De Martino","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2026.119915_bib97","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/19768354.2021.1954550","article-title":"Time-sequential change in immune-related gene expression after irradiation in glioblastoma: next-generation sequencing analysis","volume":"25","author":"Kim","year":"2021","journal-title":"Anim. Cells Syst. (Seoul. )"},{"key":"10.1016\/j.biopha.2026.119915_bib98","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2327682","article-title":"STING is significantly increased in high-grade glioma with high risk of recurrence","volume":"13","author":"Zhong","year":"2024","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biopha.2026.119915_bib99","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70187","article-title":"Spatial distribution of immune cells and their proximity to STING(+) cells are associated with survival in glioblastoma","volume":"15","author":"Jeon","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.biopha.2026.119915_bib100","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","article-title":"Effect of nivolumab vs bevacizumab in patients with recurrent glioblastoma: the checkMate 143 phase 3 randomized clinical trial","volume":"6","author":"Reardon","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.biopha.2026.119915_bib101","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.omto.2019.02.002","article-title":"The antiviral apparatus: STING and oncolytic virus restriction","volume":"13","author":"Lee","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.biopha.2026.119915_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2026.120997","article-title":"Integrating multi-omics data and artificial intelligence for personalized medicine in glioblastoma","volume":"588","author":"Abuhassan","year":"2026","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.biopha.2026.119915_bib103","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2174\/0113894501434141251223120435","article-title":"Targeting the cGAS-STING pathway in gastrointestinal cancers: modulating tumor-associated inflammation for therapeutic effect","volume":"27","author":"Rathod","year":"2026","journal-title":"Curr. Drug. Targets"},{"key":"10.1016\/j.biopha.2026.119915_bib104","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s12029-026-01423-z","article-title":"cGAS-STING pathway in gastrointestinal malignancies: mechanistic insights and translational therapeutic opportunities","volume":"57","author":"Rathod","year":"2026","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.biopha.2026.119915_bib105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41568-025-00894-9","article-title":"Opportunities and challenges of targeting cGAS-STING in cancer","volume":"26","author":"Lu","year":"2026","journal-title":"Nat. Rev. Cancer"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226009510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:03:51Z","timestamp":1790082231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226009510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":105,"alternative-id":["S0753332226009510"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119915","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Context-dependent roles of cGAS\u2013STING signaling in glioblastoma: Therapeutic resistance, drug delivery, and heterogeneity-informed translation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119915"}}